Fluvirin(TIVf)
V71_22
Approved mab completed
Quick answer
Fluvirin(TIVf) for Influenza is a Approved program (mab) at Novartis Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Novartis Pharmaceuticals
- Indication
- Influenza
- Phase
- Approved
- Modality
- mab
- Status
- completed